Moxifloxacin resistance: Intrinsic to antibiotic or related to mutation?

Optometry and Vision Science

Volumn 89, Issue 12, 2012, Pages 1721-1724

  Agarwal, Tushar ^a   Jhanji, Vishal ^b   Satpathy, Gita ^a   Nayak, Niranjan ^a   Chawla, Bhavna ^a   Tandon, Radhika ^a   Titiyal, Jeewan S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antibiotics; keratitis; moxifloxacin; resistance

Indexed keywords

GATIFLOXACIN; KERATITIS; MOXIFLOXACIN; TOBRAMYCIN;

ELECTRIC RESISTANCE; OPHTHALMOLOGY; OPTOMETERS;

ANTIBIOTICS;

ANTIINFECTIVE AGENT; HETEROCYCLIC COMPOUND; MOXIFLOXACIN; QUINOLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL EYE INFECTION; COMPARATIVE STUDY; CORNEA; CORNEA ULCER; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CORNEA; CORNEAL ULCER; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; QUINOLINES; RETROSPECTIVE STUDIES;

EID: 84871092618     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31827717d4     Document Type: Article

References (16)

1. McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg 2010;36:1588-98.
2. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HWJr. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006;124:479-83.
3. Miller DM, Vedula AS, Flynn HW, Jr, Miller D, Scott IU, Smiddy WE, Murray TG, Venkatraman AS. Endophthalmitis caused by Staphylococcus epidermidis: In vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging 2007;38:446-51.
4. Chawla B, Agarwal P, Tandon R, Titiyal JS, Sharma N, Agarwal T, Navak N, Satpathy G. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones. Eur J Ophthalmol 2010; 20:300-5.
5. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
6. Blondeau JM. Fluoroquinolones: Mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004;49(SUPPL2):S73-8.
7. Cambau E, Matrat S, Pan XS, Roth Dit Bettoni R, Corbel C, Aubry A, Lascols C, Driot JY, Fisher LM. Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 2009;63:443-50.
8. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 2004;49(SUPPL2):S79- 83.
9. Kaliamurthy J, Nelson Jesudasan CA, Geraldine P, Parmar P, Kalavathy CM, Thomas PA. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res 2005;37:117-22.
10. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use. JAMA 2003;289:885-8.
11. Sueke H, Kaye S, Neal T, Murphy C, Hall A, Whittaker D, Tuft S, Parry C. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 2010;51:2519-24.
12. Haas W, Pillar CM, Torres M, Morris TW, Sahm DF. Monitoring antibiotic resistance in ocular microorganisms: Results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol 2011;152:567-74.
13. Morrissey I, Burnett R, Viljoen L, Robbins M. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J Infect 2004;49:109-14.
14. Pong A, Thomson KS, Moland ES, Chartrand SA, Sanders CC. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. J Antimicrob Chemother 1999;44:621-7.
15. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourthgeneration fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-6.
16. Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg 2004; 30:2177-82.